Role for Bcl-x(L) in the regulation of apoptosis by EGF and TGF beta 1 in c-myc overexpressing mammary epithelial cells

被引:63
作者
Nass, SJ
Li, M
Amundadottir, LT
Furth, PA
Dickson, RB
机构
[1] GEORGETOWN UNIV, DEPT CELL BIOL, WASHINGTON, DC 20007 USA
[2] GEORGETOWN UNIV, VINCENT T LOMBARDI CANC CTR, WASHINGTON, DC 20007 USA
[3] UNIV MARYLAND, SCH MED, DEPT MED, DIV INFECT DIS, BALTIMORE, MD 21201 USA
[4] VET AFFAIRS MED CTR, BALTIMORE, MD 21201 USA
关键词
D O I
10.1006/bbrc.1996.1497
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
We previously showed that TGF alpha synergizes with c-myc in mammary tumorigenesis through inhibition of Myc-induced apoptosis. We therefore examined the effects of growth factors on apoptosis induction in several cell lines from MMTV-myc mammary tumors. When EGF was withdrawn or TGF beta 1 was added, cells became apoptotic after 15 h (by ELISA and morphology). Northern and Western analysis revealed high levels of Bax and p53, and low or undetectable levels of Bcl-2 and Bcl-x(S) under all treatment conditions. In contrast, Bcl-x(L) expression was highest in the presence of EGF or TGF alpha, with a significant reduction upon removal of EGF or exposure to TGF beta. In mouse mammary tumors, the relative Bcl-x(L)/Bax ratio was higher in TGF alpha/Myc double transgenics than in Myc single transgenics, in agreement with the in vitro data. Our results suggest a role for Bcl-x(L) in the regulation of apoptosis by EGF and TGF beta in mammary epithelial cells. (C) 1996 Academic Press, Inc.
引用
收藏
页码:248 / 256
页数:9
相关论文
共 36 条
[1]   MYC-MAX-MAD - A TRANSCRIPTION FACTOR NETWORK CONTROLLING CELL-CYCLE PROGRESSION, DIFFERENTIATION AND DEATH [J].
AMATI, B ;
LAND, H .
CURRENT OPINION IN GENETICS & DEVELOPMENT, 1994, 4 (01) :102-108
[2]  
AMUNDADOTTIR LT, 1995, CELL GROWTH DIFFER, V6, P737
[3]  
Amundadottir LT, 1996, ONCOGENE, V13, P757
[4]   Transgenic mouse models of breast cancer [J].
Amundadottir, LT ;
Merlino, G ;
Dickson, RB .
BREAST CANCER RESEARCH AND TREATMENT, 1996, 39 (01) :119-135
[5]  
ARMSTRONG DK, 1992, CANCER RES, V52, P3418
[6]  
BROOME HE, 1995, J IMMUNOL, V155, P2311
[7]   BCL-X(L) AND BCL-2 REPRESS A COMMON PATHWAY OF CELL-DEATH [J].
CHAO, DT ;
LINETTE, GP ;
BOISE, LH ;
WHITE, LS ;
THOMPSON, CB ;
KORSMEYER, SJ .
JOURNAL OF EXPERIMENTAL MEDICINE, 1995, 182 (03) :821-828
[8]  
CHAOUCHI N, 1995, ONCOGENE, V11, P1615
[9]  
DICKSON RB, 1996, DIS BREAST, P221
[10]  
HALDAR S, 1994, CANCER RES, V54, P2095